Evaluation of PD-L1 Expression Level in Patients With Non-Small Cell Lung Cancer by 18F-FDG PET/CT Radiomics and Clinicopathological Characteristics

Impact of segmentation and discretization on radiomic features in 68Ga-DOTA-TOC PET/CT images of neuroendocrine tumor

(2021) Virginia Liberini et al.   EJNMMI Physics

Deep learning radiomics can predict axillary lymph node status in early-stage breast cancer

(2020) Xueyi Zheng et al.   Nature Communications

Radiomics study for predicting the expression of PD-L1 in non-small cell lung cancer based on CT images and clinicopathologic features

(2020) Zongqiong Sun et al.   Journal of X-Ray Science and Technology

PD-L1 expression correlation with metabolic parameters of FDG PET/CT and clinicopathological characteristics in non-small cell lung cancer

(2020) Xiaodong Wu et al.   EJNMMI Research

Intratumor Heterogeneity in Early Lung Adenocarcinoma

(2020) Maria-Fernanda Senosain et al.   Frontiers in Oncology

Positive Ki-67 and PD-L1 expression in post-neoadjuvant chemotherapy muscle-invasive bladder cancer is associated with shorter overall survival: a retrospective study

(2020) Selene Rubino et al.   WORLD JOURNAL OF UROLOGY

PD-L1 in Lung Adenocarcinoma: Insights into the Role of 18F-FDG PET/CT

(2020) Yan Cui et al.   Cancer Management and Research

The role of radiomics in prostate cancer radiotherapy

(2020) Rodrigo Delgadillo et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Radiomics: an overview in lung cancer management—a narrative review

(2020) Bojiang Chen et al.   Annals of Translational Medicine

Assessing PD-L1 Expression Level by Radiomic Features From PET/CT in Nonsmall Cell Lung Cancer Patients: An Initial Result

(2019) Mengmeng Jiang et al.   ACADEMIC RADIOLOGY

Lung Cancer Recurrence: 18F-FDG PET/CT in Clinical Practice

(2019) Asha Kandathil et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Prognostic and clinicopathological value of PD-L1 expression in primary breast cancer: a meta-analysis

(2019) Wenfa Huang et al.   BREAST CANCER RESEARCH AND TREATMENT

Repeatability of Multiparametric Prostate MRI Radiomics Features

(2019) Michael Schwier et al.   Scientific Reports

LIFEx: a freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity

(2018) Christophe Nioche et al.   CANCER RESEARCH

Associations of Tumor PD-1 Ligands, Immunohistochemical Studies, and Textural Features in 18F-FDG PET in Squamous Cell Carcinoma of the Head and Neck

(2018) Rui-Yun Chen et al.   Scientific Reports

A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study

(2018) Roger Sun et al.   LANCET ONCOLOGY

Radiomics in esophageal and gastric cancer

(2018) Bert-Ram Sah et al.   Abdominal Radiology

Role of FDG PET/CT in the Eighth Edition of TNM Staging of Non–Small Cell Lung Cancer

(2018) Asha Kandathil et al.   RADIOGRAPHICS

Lung Cancer Risk Prediction Model Incorporating Lung Function: Development and Validation in the UK Biobank Prospective Cohort Study

(2017) David C. Muller et al.   JOURNAL OF CLINICAL ONCOLOGY

Responsible Radiomics Research for Faster Clinical Translation

(2017) Martin Vallières et al.   JOURNAL OF NUCLEAR MEDICINE

Heterogeneous expression of PD-L1 in pulmonary squamous cell carcinoma and adenocarcinoma: implications for assessment by small biopsy

(2017) Thomas J Gniadek et al.   MODERN PATHOLOGY

Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy

(2017) Lais Osmani et al.   SEMINARS IN CANCER BIOLOGY

A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non–Small Cell Lung Cancer

(2017) David L. Rimm et al.   JAMA Oncology

PD-L1 and gastric cancer prognosis: A systematic review and meta-analysis

(2017) Lihu Gu et al.   PLoS One

A Deep Learning-Based Radiomics Model for Prediction of Survival in Glioblastoma Multiforme

(2017) Jiangwei Lao et al.   Scientific Reports

PD-L1 expression in lung cancer and its correlation with driver mutations: a meta-analysis

(2017) Minghui Zhang et al.   Scientific Reports

Imaging Heterogeneity in Lung Cancer: Techniques, Applications, and Challenges

(2016) Usman Bashir et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Tumour CD274 (PD-L1) expression and T cells in colorectal cancer

(2016) Yohei Masugi et al.   GUT

PD-L1 Expression in Lung Cancer

(2016) Hui Yu et al.   Journal of Thoracic Oncology

Robustness of Radiomic Features in [11C]Choline and [18F]FDG PET/CT Imaging of Nasopharyngeal Carcinoma: Impact of Segmentation and Discretization

(2016) Lijun Lu et al.   MOLECULAR IMAGING AND BIOLOGY

Radiomics: Images Are More than Pictures, They Are Data

(2016) Robert J. Gillies et al.   RADIOLOGY

Control of PD-L1 Expression by Oncogenic Activation of the AKT–mTOR Pathway in Non–Small Cell Lung Cancer

(2015) Kristin J. Lastwika et al.   CANCER RESEARCH

PD-L1 Expression in Triple-Negative Breast Cancer

(2014) E. A. Mittendorf et al.   Cancer Immunology Research

Prognostic Significance of Volume-Based PET Parameters in Cancer Patients

(2013) Seung Hwan Moon et al.   KOREAN JOURNAL OF RADIOLOGY

Radiomics: Extracting more information from medical images using advanced feature analysis

(2012) Philippe Lambin et al.   EUROPEAN JOURNAL OF CANCER

Tumor heterogeneity and its implication for drug delivery

(2012) Tracy A. Denison et al.   JOURNAL OF CONTROLLED RELEASE

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

(2012) Julie R. Brahmer et al.   NEW ENGLAND JOURNAL OF MEDICINE